Trials / Completed
CompletedNCT00673309
Assessment of Mechanisms of Improved Wound Healing
Assessment of Mechanisms of Improved Wound Healing of Anabolic Agents and Diet in Severely Burned Patients
- Status
- Completed
- Phase
- Phase 2 / Phase 3
- Study type
- Interventional
- Enrollment
- 644 (actual)
- Sponsor
- The University of Texas Medical Branch, Galveston · Academic / Other
- Sex
- All
- Age
- 90 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to find ways to improve wound healing and decrease the negative effects of trauma from burn injury.
Detailed description
This study involves research and the investigators hope to learn the following: how or what effect one or more anabolic ("tissue building") agents have on muscle metabolism, wound healing, and immune function after severe burn. The agents include the following: growth hormone, insulin-like growth factor-1 in combination with its binding proteins, insulin, Beta-adrenergic blockers, Alpha Adrenergic Agonist, anabolic steroids such as testosterone, Oxandrolone and nandrolone, ketoconazole and its derivatives, dehydroepiandrosterone, fenofibrate, diet or the application of skin substitute.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | Stable Isotope Infusion study | Stable isotope infusion study to be done following each surgery. Tagged isotopes to assess uptake into blood and tissues. Includes collection of blood and tissues (muscle) |
| DRUG | Insulin High Dose | Insulin IV administered continuously throughout hospitalization until wounds are 95% healed. |
| DRUG | oxandrolone | Oxandrolone given daily throughout hospitalization until 95% wound healing. |
| DRUG | Propranolol | Propranolol to be given daily throughout hospitalization until 95% wound healing. |
| DRUG | Growth Hormone | Recombinant Human Growth hormone to be administered daily until 95% wound healing. |
| DRUG | Insulin Low Dose | Insulin administered IV until 95% wound healing |
| DRUG | IGF-1/IGFBP-3 | Insulin Like Growth Factor-1/Insulin like Growth Factor Binding Protein 3 administered until 95% wound healing |
| DRUG | Itraconazole | Itraconazole administered until 95% wound healing |
| DRUG | Growth Hormone and Propranolol | Growth Hormone and Propranolol given until 95% wound healing |
| DRUG | Oxandrolone and Propranolol | Oxandrolone and Propranolol |
| DRUG | Placebo or Control | Administration of Placebo or Control until 95% wound healing |
Timeline
- Start date
- 2000-07-01
- Primary completion
- 2011-04-01
- Completion
- 2013-04-01
- First posted
- 2008-05-07
- Last updated
- 2023-07-03
- Results posted
- 2019-12-16
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT00673309. Inclusion in this directory is not an endorsement.